Hospital Universitario HM Sanchinarro-CIOCC; Oncología Médica

Madrid 28050

0 studies enrolling now · 1 studies all time

What they study most

Advanced/Metastatic Tumors

Studies at this site

• Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors — Completed